February 2020 Clinical Watch Newsletter

March 4, 2020

In this issue of Clinical Watch, we discuss COVID-19 and suggest prior authorization criteria for immunotherapy to reduce the severity of allergic reactions to peanuts. Lastly, we review claims data for peanut allergy and use of epinephrine.


For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Article
Overcoming Payer Barriers through  the Three Pillars of Hub Onboarding: Rate, Time, Duration
Overcoming Payer Barriers through the Three Pillars of Hub Onboarding: Rate, Time, Duration

Pharmaceutical manufacturers and payers are often at odds over pricing and barriers to new medication acces...

Next Flipbook
January 2020 Clinical Watch Newsletter
January 2020 Clinical Watch Newsletter